Effective January 15, 2022, to broaden access to SARS-CoV-2 at-home testing, the Division of TennCare began coverage of rapid at-home tests with Emergency Use Authorization (EUA) through the OptumRx Pharmacy Point of Sale System.
For further questions, please contact OptumRx Provider Liaisons at tnrxeducation@optum.com
Also in Tennessee, please see updates to the TennCare Preferred Drug List, Clinical Criteria, TennCare Branded Drugs to be Classified as Generics and Interim Criteria below for February 2022. These changes went into effect on February 1st.
- Added to preferred: molnupiravir, Paxlovid
- Added to non-preferred: sertraline capsules
- Added to interim: Bylvay, Qulipta, Scemblix, Invega Hafyera, Lybalvi
- BaG removals: Xopenex, Uloric
Finally in Tennessee, Lucy A. Shell, PharmD, TPA’s Director of Pharmacy Practice Initiatives and former Interim Executive Director, was named Executive Director for the Tennessee Board of Pharmacy, effective Feb. 21.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.